Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Embody
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · Embody: October 2026
vs
Verdict57/ 100
Grade C · #404Embody
Advertises low promotional compounded GLP-1 prices, while its own terms list different program schedules.
Visit EmbodyThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 57/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Embody still earns its place — patients who will confirm the selected medication, recurring price and cancellation terms in writing before paying.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results60
92
Real-world results60
97Price honesty35
97
Price honesty35
96Prescriber access60
96
Prescriber access60
88Formulary choice65
88
Formulary choice65
95Cancellation fairness55
95
Cancellation fairness55
93Member support75
93
Member support75
Price, coverage & features
| Metric | CoreAge Rx | Embody |
|---|---|---|
| Verdict Score | 94/100 | 57/100 |
| Grade | A | C |
| Semaglutide | $99/mo | From $69/mo (advertised promotion; terms list other prices) |
| Tirzepatide | $149/mo | From $119/mo (advertised promotion; terms list other prices) |
| Coverage | All 50 states | 49 states advertised; confirm eligibility (Louisiana excluded) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Embody
What we like
- Public homepage advertises introductory and promotional prices
- Publishes separate program schedules and refund terms
- Lists compounded injections and oral gum options
The caveats
- Advertised rates differ from the prices in the company's own program terms; confirm the selected offer
- Cancel at least 72 hours before the next billing date
- Paid and prepaid bundles are generally nonrefundable; medical-disqualification refunds deduct services already performed
- Compounded medications are not FDA-approved; gums are not approved GLP-1 tablets
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Patients who will confirm the selected medication, recurring price and cancellation terms in writing before paying.
Visit Embody Read the full Embody review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Embody does the reverse.
More on CoreAge Rx
More on Embody
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.